Old Web
English
Sign In
Acemap
>
Paper
>
PRS55 - COST-EFFECTIVENESS OF MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA PATIENTS IN FRANCE
PRS55 - COST-EFFECTIVENESS OF MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA PATIENTS IN FRANCE
2018
F. Maunoury
C. Pribil
Michel Aubier
Gaëlle Nachbaur
S Doyle
Keywords:
Intensive care medicine
Mepolizumab
Eosinophilic asthma
Medicine
cost effectiveness
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]